Microbiology Research (Jul 2022)

<i>Streptomyces</i>: Still the Biggest Producer of New Natural Secondary Metabolites, a Current Perspective

  • Lavinia Donald,
  • Atanas Pipite,
  • Ramesh Subramani,
  • Jeremy Owen,
  • Robert A. Keyzers,
  • Taitusi Taufa

DOI
https://doi.org/10.3390/microbiolres13030031
Journal volume & issue
Vol. 13, no. 3
pp. 418 – 465

Abstract

Read online

There is a real consensus that new antibiotics are urgently needed and are the best chance for combating antibiotic resistance. The phylum Actinobacteria is one of the main producers of new antibiotics, with a recent paradigm shift whereby rare actinomycetes have been increasingly targeted as a source of new secondary metabolites for the discovery of new antibiotics. However, this review shows that the genus Streptomyces is still the largest current producer of new and innovative secondary metabolites. Between January 2015 and December 2020, a significantly high number of novel Streptomyces spp. have been isolated from different environments, including extreme environments, symbionts, terrestrial soils, sediments and also from marine environments, mainly from marine invertebrates and marine sediments. This review highlights 135 new species of Streptomyces during this 6-year period with 108 new species of Streptomyces from the terrestrial environment and 27 new species from marine sources. A brief summary of the different pre-treatment methods used for the successful isolation of some of the new species of Streptomyces is also discussed, as well as the biological activities of the isolated secondary metabolites. A total of 279 new secondary metabolites have been recorded from 121 species of Streptomyces which exhibit diverse biological activity. The greatest number of new secondary metabolites originated from the terrestrial-sourced Streptomyces spp.

Keywords